Abstract
We have identified an in vivo footprint over the PuF site on the translocated c-myc allele in Burkitt's lymphoma cells. The PuF site on the silent normal c-myc allele was unoccupied. We demonstrated by electrophoretic mobility shift assay, electrophoretic mobility shift assay with antibody, UV cross-linking followed by SDS-gel electrophoresis, and Western analysis that Nm23H2 in B cell nuclear extracts bound to the c-myc PuF site. Transfection experiments with c-myc promoter constructs in both DHL-9 and Raji cells revealed that the PuF site functioned as a positive regulatory element in B cells with a drop in activity with mutation of this site. Access to this site is blocked in the normal silent c-myc allele; these data suggest that the Nm23H2 protein is involved in deregulation of the translocated c-myc allele in Burkitt's lymphoma cells.
Highlights
From the Center for Molecular Biology in Medicine, VAMC, Palo Alto, California 94304 and the Department of Medicine, Stanford University School of Medicine, Stanford, California 94305
We have identified an in vivo footprint over the PuF site on the translocated c-myc allele in Burkitt's lymphoma cells
We demonstrated by electrophoretic mobility shift assay, electrophoretic mobility shift assay with antibody, UV cross-linking followed by SDS-gel electrophoresis, and Western analysis that Nm23H2 in B cell nuclear extracts bound to the e-myc PuF site
Summary
We have identified an in vivo footprint over the PuF site on the translocated c-myc allele in Burkitt's lymphoma cells. We demonstrated by electrophoretic mobility shift assay, electrophoretic mobility shift assay with antibody, UV cross-linking followed by SDS-gel electrophoresis, and Western analysis that Nm23H2 in B cell nuclear extracts bound to the e-myc PuF site.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have